The programme, which will open to its first cohort in the 2026–27 academic year, intends to enrol 100 scholars over its first 4 years.

An ‘AI scientist’, working in collaboration with human scientists, has found that combinations of cheap and safe drugs – used to treat conditions such as high cholesterol and alcohol dependence – could also be effective at treating cancer, a promising new approach to drug discovery.

Researchers at Cambridge are leading conversations to make sure we embrace AI with eyes wide open.

It’s time to cut through the hype around AI and look at how it can deliver real public value. ai@cam is at the forefront of developing artificial intelligence with purpose.